GTAM Antibodies

Santa Cruz Biotechnology features a diverse variety of GTAM Antibodies for research applications. GTAM Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GTAM, or GTPase-activating protein for Rho family GTPases, plays a crucial role in regulating cellular signaling pathways that control cell growth, differentiation, and motility. By modulating the activity of Rho GTPases, GTAM is essential for maintaining normal cellular functions and has implications in various diseases, including cancer and neurodegenerative disorders. Understanding GTAM's role in cellular processes can provide insights into potential therapeutic targets. GTAM monoclonal antibodies enable researchers to investigate signaling pathways and molecular interactions with high specificity. Advanced research techniques supported by GTAM monoclonal antibodies help identify new therapeutic approaches for disease treatment. Investigating GTAM's functions in cell regulation and disease progression continues to reveal promising directions in biomedical research. Santa Cruz Biotechnology monoclonal antibodies for GTAM research contribute to advancing scientific understanding of cellular processes and disease mechanisms.